AXT INC quarterly report, Q2 FY2014

Business Context and Reporting Period

AXT, Inc. filed an unaudited Form 10-Q for the quarter and six months ended June 30, 2014. AXT develops, manufactures and sells compound semiconductor substrates, including gallium arsenide (GaAs), indium phosphide (InP) and germanium (Ge), as well as related raw materials. Manufacturing is conducted in China, with strategic and consolidated joint ventures supporting raw-material supply.

Key Financial Metrics

MetricThree Months Ended June 30, 2014Three Months Ended June 30, 2013Six Months Ended June 30, 2014Six Months Ended June 30, 2013
Revenue$21.4 million$23.8 million$40.8 million$46.2 million
Gross profit$4.2 million$3.1 million$6.9 million$6.6 million
Gross margin19.4%12.9%16.9%14.2%
Loss from operations$(0.5) million$(2.2) million$(2.9) million$(3.4) million
Net income attributable to AXT$0.3 million$(2.0) million$(1.7) million$(4.4) million
EPS attributable to AXT$0.01$(0.06)$(0.06)$(0.14)
Net cash provided by operating activitiesNot separately providedNot separately provided$2.9 million$(0.4) million
  • Second-quarter revenue declined 10.0% year over year, while six-month revenue declined 11.7%.
  • Second-quarter revenue benefited from higher GaAs and InP sales, but Ge revenue fell 68.6% because of fewer satellite launches and weaker concentrated-photovoltaic demand.
  • At June 30, 2014, cash and cash equivalents were $26.3 million, short-term investments were $22.1 million and long-term investments were $1.0 million, for total cash and investments of approximately $49.4 million.
  • Approximately $5.8 million of cash and investments was held by consolidated joint ventures and was not available for U.S. use without incurring income taxes.
  • The company had no borrowings under its $10.0 million secured line of credit and reported no material off-balance-sheet financing arrangements.
  • Total assets were $160.7 million and total liabilities were $16.2 million at June 30, 2014.
  • Accounts receivable increased to $19.3 million from $14.9 million at December 31, 2013, while inventories declined to $35.3 million from $39.1 million.

Material Changes Versus the Prior Comparable Period

  • GaAs revenue increased 6.8% in the second quarter, reflecting stronger wireless-device demand, and InP revenue increased 48.7% on higher optical-networking demand.
  • Ge revenue decreased $3.7 million in the second quarter and $2.9 million for the six-month period, significantly offsetting growth in GaAs and InP.
  • Gross margin improved by 6.5 percentage points in the second quarter and 2.7 percentage points for the six-month period, primarily due to product mix and substrate cost-reduction initiatives. Raw-material margins declined because of lower 4N gallium selling prices.
  • Selling, general and administrative expense declined 12.3% in the second quarter and 12.4% for the six-month period, reflecting lower receivable allowances and cost savings.
  • Research and development expense declined modestly, while equity earnings from unconsolidated joint ventures increased to $0.6 million in the quarter and $1.1 million year to date.
  • Operating results included a $0.9 million restructuring charge in the first quarter related to the elimination of approximately 93 positions, or 11% of the Tongmei workforce. No additional restructuring charge was recorded in the second quarter.
  • Operating cash flow improved from an outflow of $0.4 million in the first half of 2013 to an inflow of $2.9 million in the first half of 2014, aided by lower inventory and prepaid balances, despite a $4.4 million increase in accounts receivable.

Outlook, Management Commentary, Risks and Unusual Items

Management stated that existing cash and investments were adequate to meet expected needs for the next 12 months, but warned that lower sales could reduce operating cash flow, accelerate use of cash and require additional capital. The filing does not provide a specific numerical revenue or earnings outlook in the text provided.

  • The planned second manufacturing facility in Tianjin, China, requiring a proposed AXT investment of approximately $12.5 million and an estimated $5.0 million contribution from a joint venture, was delayed because of volatility in the substrate business; management did not expect the project to proceed.
  • Major risks include semiconductor-industry cyclicality, manufacturing underutilization, product-mix volatility, declining average selling prices, customer order cancellations or delays, quality and yield issues, and intense competition.
  • International exposure is substantial: international sales represented 87% of second-quarter revenue and 89% of first-half revenue. The company is exposed to Chinese operating, regulatory, tax, currency and power-supply risks.
  • The five largest customers represented 36% of second-quarter revenue and 35% of first-half revenue, although no individual customer exceeded 10% of revenue in either period. One customer exceeded 10% of trade receivables at June 30, 2014.
  • Inventory reserves for excess and obsolete inventory were $11.8 million at June 30, 2014, up from $11.0 million at December 31, 2013. Product warranty accruals were approximately $1.0 million.
  • The company recognized a $1.8 million net-of-tax unrealized gain on its publicly traded IntelliEPI investment; the filing cautions that the company may not realize the recorded value upon sale.
  • Contractual obligations totaled $3.4 million, consisting primarily of operating leases and royalty payments. The company reported no material purchase obligations and no material legal proceedings.
  • Foreign-exchange transaction gains were $0.2 million in the second quarter and $0.2 million for the first six months, compared with losses in the prior-year periods.
  • Management reported that disclosure controls and procedures were effective as of June 30, 2014, with no material change in internal control over financial reporting during the quarter.

Important Facts for Investors to Verify

  • Whether the recovery in second-quarter GaAs and InP demand is sustainable and can offset continued weakness in Ge and raw-material pricing.
  • Whether cost reductions and the Tongmei workforce restructuring can maintain improved gross margins despite underutilized capacity and pricing pressure.
  • The collectability and aging of the increased accounts receivable balance, including exposure to the customer representing more than 10% of receivables.
  • The potential for additional inventory write-downs beyond the $11.8 million reserve.
  • The liquidity impact of cash held at Chinese joint ventures, tax costs on repatriation and any future capital requirements.
  • The valuation and market risk associated with the IntelliEPI equity investment and other private-company investments in China.
  • The effect of foreign-exchange movements, Chinese regulatory or tax changes, supply interruptions and customer concentration on future results.
  • The status of the delayed Tianjin expansion and whether any future decision to proceed would require significant capital expenditures.